Korro Bio
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Korro Bio generated cash of -$67,283,000, which is less than the previous year. Cash used in financing activities reached the amount of $187,761,000 last year. Net change in cash is therefore $131,642,000.
Cash Flow
| 2017 | -14.61M | -1.86M | 27.97M |
|---|---|---|---|
| 2019 | 34.21M | -18.26M | 142.01M |
| 2020 | -45.18M | 10.40M | 56.68M |
| 2021 | -32.09M | -39.50M | 115.94M |
| 2022 | -53.64M | 11.06M | 18K |
| 2023 | -67.28M | 11.16M | 187.76M |
KRRO Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 41.47M | 84.04M | 39.69M | 200.15M | 42.18M | 6.43M |
Operating activities | ||||||
Net income | -81.17M | -58.03M | -21.95M | -26.51M | -18.74M | -20.23M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 3.63M | 2.51M | 1.59M | 1.58M | 813K | 531K |
Stock-based compensation expense | 2.38M | 1.14M | 807K | 0 | 0 | 0 |
| Deferred income tax benefit | 2.38M | 1.14M | 807K | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 3.1M | 1.75M | 56K | 4.28M | -644K | 0 |
Cash generated by operating activities | -67.28M | -53.64M | -32.09M | -45.18M | 34.21M | -14.61M |
Investing activities | ||||||
Purchases Of Investments | 0 | -37.21M | -35.06M | -26.34M | -282.61M | 0 |
Investments In Property Plant And Equipment | -7.83M | -5.21M | -4.44M | -6.67M | -1.06M | -1.86M |
Acquisitions Net | 0 | 0 | -29.23M | 0 | 0 | 0 |
Cash generated by investing activities | 11.16M | 11.06M | -39.50M | 10.40M | -18.26M | -1.86M |
Financing activities | ||||||
Common Stock Issued | 117.25M | 62K | 1.35M | 41.68M | 142.01M | 27.97M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -15M | 0 | 0 |
Cash used in financing activities | 187.76M | 18K | 115.94M | 56.68M | 142.01M | 27.97M |
Net Change In Cash | 131.64M | -42.56M | 44.35M | 20.18M | 157.96M | 11.50M |
Cash at end of period | 173.11M | 41.47M | 84.04M | 220.34M | 200.15M | 17.93M |